BMO cuts Meta stock price target on AI spending concerns

Meta delivered a strong Q1 2026 beat, with revenue 2% above consensus and operating income 21% above estimates, but the stock was pressured by concerns over AI return on investment and rising capex. BMO cut its price target to $720 from $730 and lifted 2026/2027 capex estimates to $141 billion and $169 billion, respectively. The Q2 revenue guide of $58 billion to $61 billion was only in line with consensus at the midpoint, tempering the earnings strength.

Analysis

The market is starting to treat Meta less like a cash compounder and more like a utility underwriting a multi-year AI capex cycle with uncertain payback. That re-rating matters because the stock has historically been able to absorb higher spend only when revenue growth visibly re-accelerates; if top-line growth merely tracks expectations while capex steps up, margin durability becomes the key debate, not earnings quality. In that regime, the downside is not from a single quarter miss but from a longer compression in free cash flow multiple as investors reset what “normal” reinvestment looks like.

Second-order, the capex intensity is likely to support the infrastructure winners even if it pressures Meta’s equity multiple. The better relative trades are in picks-and-shovels beneficiaries where spending is already committed and visibility is higher than the end-user ROI equation: networking, interconnect, and power/cooling capacity. The risk is that the market eventually distinguishes between discretionary model-training spend and revenue-producing deployment spend, which could punish vendors tied to the former if hyperscaler budgets get scrutinized in 2H26.

The contrarian view is that consensus may be underestimating Meta’s ability to monetize AI through ad load, conversion optimization, and engagement rather than direct AI subscription revenue. If that thesis starts showing up in sustained ad pricing or better-than-expected margin resilience over the next 2-3 quarters, the current skepticism will look too early. But until there is evidence that each incremental dollar of capex is translating into either faster revenue growth or lower acquisition costs, the stock is vulnerable to being capped by rising free cash flow skepticism rather than headline earnings beats.

JPM’s involvement broadens the signal: this is no longer a single-name debate, but a cross-cyclical concern about whether mega-cap AI spend can justify current valuation premia. If investors become more selective, capital may rotate from the platform names to suppliers with clearer order books and less ROI ambiguity. That creates a window where Meta can underperform even on decent operating results, simply because the market is moving from growth-at-any-cost to proof-of-return.

Key Decisions for Investors

• Reduce META exposure tactically over the next 1-4 weeks into strength; use any post-earnings bounce to trim, since the risk/reward skews toward multiple compression if capex keeps outpacing visible monetization.
• Go long EQIX vs short META for 1-3 months as a relative-value expression on AI infrastructure spend; EQIX benefits from committed cloud/network demand while META bears the burden of uncertain payoff.
• Buy META downside via 3-6 month put spreads rather than outright shorts; the thesis is valuation de-rating, not an immediate earnings collapse, so defined-risk structures fit better.
• Overweight AI infrastructure beneficiaries with visible backlog and power demand exposure on a 3-12 month horizon; the second-order winners should outperform as investors separate spend recipients from spend originators.
• If META shows a follow-up quarter with flat-to-improving ad yield or margin stability despite higher capex, cover bearish exposure quickly; that would be the first credible sign the market is underestimating AI monetization.